Causes and Risk Factors for Atrial Fibrillation

Epidemiology and Demographics

More than 70 % of atrial fibrillation (AF) patients are older adults who have underlying cardiac or systemic conditions that trigger and maintain the arrhythmia. 1
AF prevalence rises from < 1 % in individuals younger than 50 years to ≈ 4 % at 65 years and ≈ 12 % at 80 years or older. 2

Structural Cardiac Causes

Valvular heart disease, especially mitral valve pathology, is a major structural substrate for AF. 3
Hypertension increases AF risk ≈ 1.5‑fold in men and ≈ 1.4‑fold in women, particularly when left‑ventricular hypertrophy is present. 4
Heart failure confers the highest risk, with odds ratios of 4.5 in men and 5.9 in women. 3
Coronary artery disease and myocardial infarction, especially in older patients with left‑ventricular dysfunction, elevate AF risk. 5
Cardiomyopathies (hypertrophic, dilated, restrictive) are associated with AF development. 6
Congenital heart disease, notably atrial septal defect in adults, contributes to AF. 4

Non‑Cardiac Medical Conditions

Obesity is an independent AF risk factor; progressive left‑atrial dilation occurs as body‑mass index rises from normal to overweight to obese. 7
Hyperthyroidism and other metabolic disorders act as acute triggers for AF. 1
Diabetes mellitus increases AF risk, with a stronger effect observed in women. 3
Obstructive sleep apnea promotes AF through intermittent hypoxia, autonomic imbalance, and systemic hypertension. 5
Chronic kidney disease induces electrophysiological alterations that favor AF. 2

Acute Reversible Triggers

Excessive alcohol intake (“holiday heart syndrome”) can precipitate AF. 8
Cardiac or thoracic surgery is a common early postoperative cause of AF. 6
Acute inflammatory conditions such as pericarditis and myocarditis may trigger AF. 1
Pulmonary embolism and other acute pulmonary diseases can precipitate AF. 2
Electrocution is a rare but documented trigger for AF. 8
Successful treatment of the underlying acute condition frequently eliminates AF. 6

Drug‑Induced Atrial Fibrillation

Various cardiovascular, non‑cardiovascular, and anticancer drugs can induce or exacerbate AF. 9
Drug‑induced AF is especially relevant in elderly patients with multimorbidity receiving polypharmacy. 9
Most drug‑induced AF episodes are paroxysmal, terminating within 7 days, though they may become persistent. 9
Although not featured in major AF management guidelines, drug‑induced AF is addressed in the 2022 European Society of Cardiology (ESC) cardio‑oncology guidelines. 9

Genetic and Familial Factors

Familial (lone) AF is more common than previously recognized, with increased occurrence among first‑degree relatives. 3
Offspring of parents with AF have a higher likelihood of developing the arrhythmia. 3
Monogenic AF results from mutations in ion‑channel genes that also underlie inherited electrical diseases (e.g., long QT, Brugada syndromes). 10
Common genetic variants at ≥ 17 loci, particularly chromosome 4q25 near the PITX2 gene, are associated with early‑onset AF. 10

Autonomic and Lifestyle Influences

Fluctuations in autonomic tone precede AF onset, highlighting the role of autonomic influences in initiation. 3
Vagal predominance can trigger AF in patients with structurally normal hearts, whereas sympathetic predominance is observed in others. 6
High‑intensity endurance training in middle‑aged individuals is an emerging risk factor, mediated by elevated parasympathetic tone or structural cardiac changes. 10

Pathophysiological Mechanisms

Electrophysiological alterations—including shortened atrial action‑potential duration, reduced effective refractory period, and disturbed intracellular calcium handling—create an arrhythmogenic substrate. 1
Structural remodeling characterized by atrial dilation, fibrosis, hypertrophy, and inflammation supports AF maintenance. 1
Ion‑channel dysfunction arising from altered expression or post‑translational modification contributes to AF susceptibility. 10
Abnormal calcium homeostasis, with elevated diastolic calcium and sarcoplasmic‑reticulum dysfunction, underlies AF pathogenesis. 10

Age‑Related Changes

Age‑related atrial fibrotic remodeling and increased myocardial stiffness generate a substrate for AF. 6

Lone Atrial Fibrillation

Approximately 30‑45 % of paroxysmal AF and 20‑25 % of persistent AF occur in younger patients without identifiable underlying disease (lone AF). 3
Over time, an underlying disease may become apparent in patients initially classified as having lone AF. 4
In elderly patients, structural cardiac changes associated with aging may be linked to AF, but co‑existing heart disease can be coincidental rather than causal. 3

Evidence‑Based Risk Factors and Mechanisms for Rapid Atrial Fibrillation

Structural Cardiac Causes

Valvular disease, particularly mitral valve pathology, increases the risk of atrial fibrillation (AF) by 1.8‑ to 3.4‑fold; left‑sided stenotic lesions confer the highest risk, reaching up to 70 % prevalence in combined mitral‑tricuspid disease. 11
Heart‑failure severity correlates with AF prevalence: < 5 % in NYHA class I, rising to > 50 % in class IV. Non‑ischemic, ischemic, and restrictive cardiomyopathies each show AF prevalence > 20 %. 11, 12
Hypertension elevates AF risk approximately 1.5‑fold in men and 1.4‑fold in women, especially when left‑ventricular hypertrophy is present. 13
Coronary artery disease and myocardial infarction, particularly in older patients with left‑ventricular dysfunction, raise AF incidence and are associated with a poorer prognosis. 14, 13
Adult atrial septal defects (a form of congenital heart disease) constitute a notable contributor to AF development. 13

Systemic Medical Conditions

Hyperthyroidism heightens AF risk: relative risk 1.2‑4 × with subclinical disease and 3‑6 × with overt disease, increasing as thyroid‑stimulating hormone levels fall. 11, 12
Obesity is an independent AF risk factor; progressive left‑atrial enlargement accompanies rising body‑mass index from normal through overweight to obese categories. 13
Chronic kidney disease induces electrophysiological alterations that favor AF onset. 15

Reversible Acute Triggers

Excessive alcohol intake (“holiday‑heart” syndrome) can precipitate AF episodes. 14, 13
Cardiac or thoracic surgery leads to early postoperative AF in 30‑60 % of patients, most commonly on postoperative days 2‑3. 16, 13
Acute inflammatory conditions—including pericarditis, myocarditis, and pulmonary embolism—may trigger AF. 14, 13
Development of AF during an acute myocardial infarction signals an adverse prognostic outlook. 14, 13
Metabolic disturbances such as hypoglycemia increase susceptibility to AF. 16

Genetic and Familial Factors

Familial (solitary) AF occurs in 30‑45 % of paroxysmal and 20‑25 % of persistent cases among young patients without identifiable structural disease. 14, 13
Specific genetic loci, especially chromosome 4q25 near the PITX2 gene, are associated with early‑onset AF. 12

Physiopathologic Mechanisms of Rapid Ventricular Response

Enhanced AV‑node conduction driven by sympathetic activation, catecholamines, pain, volume depletion, anemia, or fever accelerates ventricular rates during AF. 16
Autonomic imbalance with sympathetic predominance further speeds ventricular response. 15
Electrical remodeling—characterized by shortened atrial action‑potential duration, reduced effective refractory period, and altered intracellular calcium handling—creates an arrhythmogenic substrate that promotes rapid ventricular response. 17, 15

Structural Remodeling and Fibrosis

Atrial fibrosis is a common hallmark of both experimental and clinical AF; its extent correlates with increased stroke risk and diminished success of catheter ablation. 17, 15
Age‑related atrial fibrotic remodeling and heightened myocardial stiffness provide a substrate conducive to AF development. 15
Predominant vagal tone can precipitate AF even in hearts without structural abnormalities. 15

Etiologies and Risk Factors for Atrial Fibrillation

Structural Cardiac Causes

The majority of atrial fibrillation (AF) patients (70‑80%) have underlying organic heart disease, while 20‑45% develop AF without identifiable structural disease, especially in younger individuals【18】【19】.
Mitral valve disease is the most common valvular cause of AF; left‑sided stenotic lesions are associated with up to a 70 % prevalence of AF when mitral and tricuspid disease coexist【18】.
Both mitral valve prolapse (with or without regurgitation) and calcification of the mitral annulus increase the incidence of AF【18】.
Hypertrophic, dilated, and restrictive cardiomyopathies (including amyloidosis, hemochromatosis, and endomyocardial fibrosis) predispose to AF【18】【19】.
Hypertension raises AF risk by ~1.5‑fold in men and ~1.4‑fold in women, particularly when left‑ventricular hypertrophy is present【18】.
Coronary artery disease and myocardial infarction increase AF risk, especially in older patients with left‑ventricular dysfunction【18】.
Development of AF during an acute myocardial infarction is linked to a worse prognosis compared with pre‑infarct AF or sinus rhythm【18】【20】.
Atrial septal defect in adults is a notable contributor to AF development【18】【19】.
Other structural cardiac conditions associated with AF include cardiac tumors, constrictive pericarditis, cor pulmonale, and idiopathic right‑atrial dilation【18】【19】.

Reversible and Acute Triggers

Excessive alcohol consumption (“holiday heart syndrome”) can precipitate AF episodes【18】【20】.
Caffeine has been listed as a potential, though less well‑established, trigger for AF【18】.
Cardiac or thoracic surgery is a common early postoperative trigger, occurring in 30‑60 % of patients, typically on postoperative days 2‑3【18】.
Acute inflammatory or pulmonary conditions—including pericarditis, myocarditis, pulmonary embolism, and other acute lung diseases—can trigger AF【18】【21】.
Successful treatment of these acute conditions frequently eliminates the associated AF【18】.
Rare triggers such as electrocution have been documented to provoke AF【18】.
Non‑cardiac surgeries, including esophageal procedures, can also act as acute AF triggers【18】.

Systemic Medical Conditions

Obesity is an independent risk factor for AF; progressive left‑atrial dilation occurs as body‑mass index rises from normal to overweight to obese categories【18】【19】.
Weight‑loss interventions have been linked to regression of left‑atrial enlargement【18】【19】.
Obstructive sleep apnea promotes AF through intermittent hypoxia, autonomic imbalance, and systemic hypertension【18】.
Pheochromocytoma, a rare catecholamine‑secreting tumor, is associated with AF development【18】.

Autonomic Influences

Vagal‑mediated AF shows a male predominance (4:1), typical onset at age 40‑50, occurrence at night or after meals, and is often preceded by bradycardia【21】.
Both beta‑blockers and digitalis may paradoxically increase the frequency of vagally mediated AF【21】.
Adrenergic‑mediated AF tends to start during daytime, is provoked by exercise or emotional stress, and is linked to specific sinus‑rate thresholds; beta‑blockers are the treatment of choice for this form【21】.
Fluctuations in autonomic tone (balance between sympathetic and vagal activity) commonly precede AF onset【22】.

Genetic and Familial Factors

Approximately 30‑45 % of paroxysmal AF and 20‑25 % of persistent AF occur in younger patients without demonstrable underlying disease (“lone AF”)【18】【19】.
The risk of developing AF is increased in individuals whose parents have a history of AF【19】【22】.

Neurogenic Causes

Subarachnoid hemorrhage and major non‑hemorrhagic stroke can precipitate AF【18】【22】.

Age‑Related Changes

Age‑related atrial fibrotic remodeling and increased myocardial stiffness create a substrate for AF; prevalence rises from <1 % in persons <50 years to ≈12 % in those ≥80 years【18】.

Electrophysiological Mechanisms

Enhanced automaticity (focal AF) and conduction abnormalities (re‑entry) are fundamental mechanisms underlying AF initiation【18】【22】.
AF is frequently associated with other atrial arrhythmias such as atrial flutter, Wolff‑Parkinson‑White syndrome, and AV‑nodal re‑entrant tachycardia; treatment of these primary arrhythmias reduces recurrent AF incidence【18】【20】.

Clinical Considerations

Patients initially classified as having “lone AF” may later reveal an underlying disease, underscoring the need for ongoing surveillance【18】【19】.
Distinguishing whether AF is a consequence of comorbid conditions or a coincidental finding in elderly patients with multiple comorbidities remains a clinical challenge【18】.